Association of DRD2 and DRD3 polymorphisms with Parkinson's disease in a multiethnic consortium

Journal of the Neurological Sciences

Volumn 307, Issue 1-2, 2011, Pages 22-29

  McGuire, V ^a   Den Eeden, S K Van ^b   Tanner, C M ^c   Kamel, F ^d   Umbach, D M ^d   Marder, K ^e,f   Mayeux, R ^e,f   Ritz, B ^g   Ross, G W ^h,i   Petrovitch, H ^h,i   Topol, B ^a   Popat, R A ^a   Costello, S ^g,j   Manthripragada, A D ^a,g,k   Southwick, A ^a,l   Myers, R M ^a,l   Nelson, L M ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DIVISION OF RESEARCH   (United States)

^c PARKINSON S INSTITUTE   (United States)

^d NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^e College of Physicians and Surgeons ^*  (United States)

^f Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h VETERANS AFFAIRS MEDICAL CENTER   (United States)

ⁱ PACIFIC HEALTH RESEARCH INSTITUTE   (United States)

^j UNIVERSITY OF CALIFORNIA   (United States)

^k CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^l HUDSONALPHA INSTITUTE FOR BIOTECHNOLOGY   (United States)

more..

Author keywords

Case control studies; Dopamine receptor genes; Epidemiology; Parkinson's disease

Indexed keywords

DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ADULT; AFRICAN AMERICAN; AGED; ALLELE; ARTICLE; ASIAN; CASE CONTROL STUDY; CONTROLLED STUDY; EXON; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC RISK; HETEROZYGOTE; HISPANIC; HOMOZYGOTE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; RACE DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; TELECONSULTATION;

AFRICAN AMERICANS; AGED; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HETEROZYGOTE DETECTION; HISPANIC AMERICANS; HUMANS; MALE; MIDDLE AGED; MULTIGENE FAMILY; NORTH AMERICA; PARKINSON DISEASE; POLYMORPHISM, GENETIC; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; RISK ASSESSMENT;

EID: 79959817711     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2011.05.031     Document Type: Article

References (30)

1. E.P. Noble D2 dopamine receptor gene in psychiatric and neurologic disorders and its phenotype Am J Med Genet 116B 2003 103 125 (Pubitemid 37063624)
2. B. Ritz, A. Ascherio, H. Checkoway, K.S. Marder, L.M. Nelson, and W.A. Rocca Pooled analysis of tobacco use and risk of Parkinson disease Arch Neurol 64 2007 990 997 (Pubitemid 47047999)
3. M.D. Li, J.Z. Ma, and J. Beuten Progress in searching for susceptibility loci and genes for smoking-related behaviour Clin Genet 66 2004 382 392 (Pubitemid 39429734)
4. M. Munafò, T. Clark, E. Johnstone, M. Murphy, and R. Walton The genetic basis for smoking behavior: a systematic review and meta-analysis Nicotine Tob Res 6 2004 583 597 (Pubitemid 39248145)
5. P. Costa-Mallen, L.G. Costa, T. Smith-Weller, G.M. Franklin, P.D. Swanson, and H. Checkoway Genetic polymorphism of dopamine D2 receptors in Parkinson's disease and interactions with cigarette smoking and MAO-B intron 13 polymorphism J Neurol Neurosurg Psychiatry 69 2000 535 537
6. R.L. Oliveri, G. Annesi, M. Zappia, D. Civitelli, E.V. De Marco, and A.A. Pasqua The dopamine D2 receptor gene is a susceptibility locus for Parkinson's disease Mov Disord 15 2000 127 131 (Pubitemid 30037997)
7. L. Grevle, C. Güzey, H. Hadidi, R. Brennersted, J.R. Idle, and J. Aasly Allelic association between the DRD2 TaqI A polymorphism and Parkinson's disease Mov Disord 15 2000 1070 1074
8. E.K. Tan, Y. Tan, A. Chai, C. Tan, H. Shen, and S.Y. Lum Dopamine D2 receptor TaqIA and TaqIB polymorphisms in Parkinson's disease Mov Disord 18 2003 593 595 (Pubitemid 36656546)
9. R.C. Juyal, M. Das, S. Punia, M. Behari, G. Nainwal, and S. Singh Genetic susceptibility to Parkinson's disease among South and North Indians: I. Role of polymorphisms in dopamine receptor and transporter genes and association of DRD4 120-bp duplication marker Neurogenetics 7 2006 223 229 (Pubitemid 44584075)
10. H.C. Fung, S. Scholz, M. Matarin, J. Simón-Sánchez, D. Hernandez, and A. Britton Genome-wide genotyping in Parkinson's disease and neurologically normal controls: first stage analysis and public release of data Lancet Neurol 5 2006 911 916 (Pubitemid 44556544)
11. F.D. Dick, G. De Palma, A. Ahmadi, A. Osborne, N.W. Scott, and G.J. Prescott Gene-environment interactions in parkinsonism and Parkinson's disease: the Geoparkinson study Occup Environ Med 64 2007 673 680 (Pubitemid 47488094)
12. M. Singh, A.J. Khan, P.P. Shah, R. Shukla, V.K. Khanna, and D. Parmar Polymorphism in environment responsive genes and association with Parkinson disease Mol Cell Biochem 312 2008 131 138
13. B.H. Keeling, C. Vilarino-Guell, O.A. Ross, Z.K. Wszolek, R.J. Uitti, and M.J. Farrer DRD3 Ser9Gly and HS1BP3 Ala265Gly are not associated with Parkinson's disease Neurosci Lett 461 2009 74 75
14. S.K. Van Den Eeden, C.M. Tanner, A.L. Bernstein, R.D. Fross, A. Leimpeter, and D.A. Bloch Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity Am J Epidemiol 157 2003 1015 1022 (Pubitemid 36628805)
15. M.C. Alavanja, D.P. Sandler, S.B. McMaster, S.H. Zahm, C.J. McDonnell, and C.F. Lynch The agricultural health study Environ Health Perspect 104 1996 362 369 (Pubitemid 26160821)
16. R. Mayeux, K. Marder, L.J. Cote, J. Denaro, N. Hemenegildo, and H. Mejia The frequency of idiopathic Parkinson's disease by age, ethnic group, and sex in northern Manhattan, 1988-1993 Am J Epidemiol 142 1995 820 827
17. K. Marder, G. Logroscino, B. Alfaro, H. Mejia, A. Halim, and E. Louis Environmental risk factors for Parkinson's disease in an urban multiethnic community Neurology 50 1998 279 281 (Pubitemid 28106054)
18. D.M. Morens, J.W. Davis, A. Grandinetti, G.W. Ross, J.S. Popper, and L.R. White Epidemiologic observations on Parkinson's disease: incidence and mortality in a prospective study of middle-aged men Neurology 46 1996 1044 1050 (Pubitemid 26134649)
19. G.A. Kang, J.M. Bronstein, D.L. Masterman, M. Redelings, J.A. Crum, and B. Ritz Clinical characteristics in early Parkinson's disease in a central California population-based study Mov Disord 20 2005 1133 1142 (Pubitemid 41632200)
20. J.W. Langston, H. Widner, D. Goetz, D. Brooks, S. Fahn, and T. Freeman Core assessment program for intracerebral transplantations (CAPIT) Mov Disord 7 1992 2 13
21. A.J. Hughes, Y. Ben-Shlomo, S.E. Daniel, and A.J. Lees What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study Neurology 42 1992 1142 1146 [published erratum In Neurology 1992;42:1436]
22. J. Sambrook, E.F. Fritsch, and T. Maniatis Molecular cloning A Laboratory Manual. 1989 Cold Spring Harbor Laboratory Press New York
23. J.F. Troendle Multiple comparisons between two groups on multiple Bernoulli outcomes while accounting for covariates Stat Med 24 2005 3581 3591 (Pubitemid 41700844)
24. C.M. Lill, S. Bagade, M.B. McQueen, J.T. Roehr, F. Kavvoura, and B.M.M. Schjeide The PDGene Database Alzheimer Research Forum December 8 2009 Available at: http://www.pdgene.org/ Accessed December 8, 2009
25. J. Gelernter, H. Kranzler, J.F. Cubells, H. Ichinose, and T. Nagatsu DRD2 allele frequencies and linkage disequilibria, including the -141CIns/Del promoter polymorphism, in European-American, African-American, and Japanese subjects Genomics 51 1998 21 26 (Pubitemid 28373369)
26. M.J. Neville, E.C. Johnstone, and R.T. Walton Identification and characterization of ANKK1: a novel kinase gene closely linked to DRD2 on chromosome band 11q23.1 Hum Mutat 23 6 2004 540 545 (Pubitemid 38720604)
27. B.Z. Yang, H.R. Kranzler, H. Zhao, J.R. Gruen, X. Luo, and J. Gelernter Haplotypic variants in DRD2, ANKK1, TTC12 and NCAM1 are associated with comorbid alcohol and drug dependence Alcoholism: Clin Exp Res 32 2008 2117 2127
28. J. Gelernter, Y. Yu, R. Weiss, K. Brady, C. Panhuysen, and B.Z. Yang Haplotype spanning TTC12 and ANKK1, flanked by the DRD2 and NCAM loci, is strongly associated to nicotine dependence in two distinct American populations Hum Mol Genet 15 2006 3498 3507 (Pubitemid 44884117)
29. W. Huang, T.J. Payne, J.Z. Ma, J. Beuten, R.T. Dupont, and N. Inohara Significant association of ANKK1 and detection of a functional polymorphism with nicotine dependence in an African-American sample Neuropsychopharmacology 34 2008 319 330
30. A.H. Wong, C.E. Buckle, and H.H. Van Tol Polymorphisms in dopamine receptors: what do they tell us? Eur J Pharmacol 410 2000 183 203 (Pubitemid 32008143)